NCT04470050 - Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal | Biotech Hunter

Enrollment

225

Participants

Timeline

Start Date

June 9, 2020

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions

Opioid Withdrawal

Interventions

DRUG

Dexmedetomidine

Sublingual Film of Dexmedetomidine

DRUG

Placebo

Sublingual Placebo film

Trial Locations (3)

BioXcel Clinical Research Site, New York

BioXcel Clinical Research Site, Miami Lakes

BioXcel Clinical Research Site, Marlton